ARCA biopharma

ARCA biopharma is a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. It is headquartered in Westminster, Colorado.

P/E

Net profit

P/B

Book value

P/FCF

FCF

Yield

Growth potential

Report period	2018	2019	2020	2021	2022	Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Report period	2018	2019	2020	2021	2022	Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Report period	2018	2019	2020	2021	2022	Q3 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Report period	2018	2019	2020	2021	2022	Q3 23 TTM
ROA
ROE
ROS

Ticker	Name	Type	Nominal value	ISIN	Price
ABIO:US	ARCA biopharma	Common share	-	US00211Y5069	$4.16

ARCA biopharma news

10.05.2022

ARCA biopharma's GAAP loss for 3 months of 2022 was $3.272 million, down 20.2% from $4.1 million in the previous year.

Source:

arcabio.com

14.03.2022

ARCA biopharma's GAAP loss for 2021 was $19.322 million, doubling from $9.738 million in the previous year.

Source:

arcabio.com

All ARCA biopharma news

General information

Company name	ARCA biopharma
Tags	#biotechnology
Sector	Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address	10170 Church Ranch Way Suite 100 Westminster, CO 80021 United States
Mailing address	10170 Church Ranch Way Suite 100 Westminster, CO 80021 United States
Website	arcabio.com
Information disclosure	www.sec.gov

ARCA biopharma

ARCA biopharma balance sheet

ARCA biopharma cash flows

ARCA biopharma multipliers

ARCA biopharma profitability

ARCA biopharma dividend policy

ARCA biopharma shares